Article
Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy.
Cancer chemotherapy and pharmacology - 1 Aug 2010
Nogueira Augusto, Catarino Raquel, Coelho Ana, Araújo António, Gomes Mónica, Medeiros Rui
Abstract excerpt
PURPOSE: Lung cancer continues to be the most frequent cancer with approximately one million people worldwide dying of this disease each year. Non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all lung cancers. The RAD51 protein is the key protein for homologous recombination, an evolutionarily conserved mechanism for DNA damage repair and the generation of genetic diversity. We conducted this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
